NITOCOGENE PARVEC
UNII YMD4FFN5TG

Substance Identification & Data

This profile provides standardized clinical and technical data for Nitocogene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YMD4FFN5TG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033896-03-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
YMD4FFN5TG
CAS Registry Number
3033896-03-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NITOCOGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13794
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nitocogene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NITOCOGENE PARVEC

Common Names & Synonyms

NITOCOGENE PARVEC [INN]
RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS VECTOR OF SYNTHETIC LIVER-TROPIC SEROTYPE 843 (RAAV843) ENCODING A CODON-OPTIMISED TRUNCATED (B DOMAIN-DELETED) VARIANT OF HUMAN BLOOD COAGULATION FACTOR VIII (HF8) PRECEDED BY A KOZAK SEQUENCE AND WITH EXPRESSION UNDER CONTROL OF A SYNTHETIC LIVER-SPECIFIC PROMOTER (LXP-2.1) AND A SYNTHETIC MINIATURE POLYADENYLATION SIGNAL BASED ON THE RABBIT BETA-GLOBIN POLYADENYLATION SIGNAL; FLANKED BY ADENO-ASSOCIATED VIRUS 2 (AAV2) INVERTED TERMINAL REPEATS (ITRS). AN ARTIFICIAL 8 AMINO ACID LINKER SEQUENCE CONNECTS THE N-TERMINAL PART WITH THE C-TERMINAL PART OF THE F8 TRANSGENE